National Institute of Statistic and Geography (2022) Press Release No. 74/22 2 Statistics about World Cancer Day (February 4) National Data. Published February 2, 2022. Accessed 9 Apr 2022. https://www.inegi.org.mx/contenidos/saladeprensa/aproposito/2022/EAP_CANCER22.pdf

Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191–203. https://doi.org/10.1016/S2214-109X(19)30482-6.

Article  PubMed  Google Scholar 

Castle PE, Jeronimo J, Temin S, Shastri SS. Screening to prevent invasive cervical cancer: ASCO resource-stratified clinical practice guideline. J Clin Oncol. 2017;35(11):1250–2. https://doi.org/10.1200/JCO.2016.71.6563.

Article  PubMed  Google Scholar 

Lopez MS, Baker ES, Maza M, et al. Cervical cancer prevention and treatment in Latin America. J Surg Oncol. 2017;115(5):615–8. https://doi.org/10.1002/jso.24544.

Article  PubMed  PubMed Central  Google Scholar 

Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12–9. https://doi.org/10.1002/(SICI)1096-9896(199909)189:1%3c12::AID-PATH431%3e3.0.CO;2-F.

Article  CAS  PubMed  Google Scholar 

Ahmad I, Pansota M, Saeed Tariq M, Shahzad Saleem M, Ali Tabassum S, Hussain A. Comparison between double J (DJ) ureteral stenting and percutaneous nephrostomy (PCN) in obstructive uropathy. Pak J Med Sci. 2013. https://doi.org/10.12669/pjms.293.3563.

Article  PubMed  PubMed Central  Google Scholar 

Plesinac-Karapandzic V, Masulovic D, Markovic B, et al. Percutaneous nephrostomy in the management of advanced and terminal-stage gynecologic malignancies: outcome and complications. Eur J Gynaec Oncol. 2010;31(6):645–50.

Google Scholar 

Lapitan MCM, Buckley BS. Impact of palliative urinary diversion by percutaneous nephrostomy drainage and ureteral stenting among patients with advanced cervical cancer and obstructive uropathy: a prospective cohort. J Obstet Gynaecol Res. 2011;37(8):1061–70. https://doi.org/10.1111/j.1447-0756.2010.01486.x.

Article  PubMed  Google Scholar 

Kakmlesh M, Ava D, Shilpa P, Meeta M, Kalpana D. Role of percutaneous nephrostomy in advanced cervical carcinoma with obstructive uropathy: a case series. Indian J Palliat Care. 2009. https://doi.org/10.4103/0973-1075.53510.

Article  Google Scholar 

Saleh M, Virarkar M, Javadi S, Elsherif SB, de Castro FS, Bhosale P. Cervical cancer: 2018 revised international federation of gynecology and obstetrics staging system and the role of imaging. AJR Am J Roentgenol. 2020;214(5):1182–95. https://doi.org/10.2214/AJR.19.21819.

Article  PubMed  Google Scholar 

Rose PG, Ali S, Whitney CW, Lanciano R, Stehman FB. Impact of hydronephrosis on outcome of stage IIIB cervical cancer patients with disease limited to the pelvis, treated with radiation and concurrent chemotherapy: a gynecologic oncology group study. Gynecol Oncol. 2010;117(2):270–5. https://doi.org/10.1016/j.ygyno.2010.01.045.

Article  PubMed  Google Scholar 

Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri. Int J Gynaecol Obstet. 2018;143:22–36. https://doi.org/10.1002/ijgo.12611.

Article  PubMed  Google Scholar 

Li F, Guo H, Qiu H, et al. Urological complications after radical hysterectomy with postoperative radiotherapy and radiotherapy alone for cervical cancer. Medicine (Baltimore). 2018. https://doi.org/10.1097/MD.0000000000010173.

Article  PubMed  PubMed Central  Google Scholar 

Chuang L, Temin S, Camacho R, Duenas-Gonzalez A, Feldman S. Management and care of women with invasive cervical cancer: american society of clinical oncology resource-stratified clinical practice guideline. J Glob Oncol. 2016. https://doi.org/10.1200/JGO.2016.003954.

Article  PubMed  PubMed Central  Google Scholar 

Tan S, Tao Z, Bian X, et al. Ureteral stent placement and percutaneous nephrostomy in the management of hydronephrosis secondary to cervical cancer. Eur J Obstet Gynecol Reprod Biol. 2019;241:99–103. https://doi.org/10.1016/j.ejogrb.2019.08.020.

Article  PubMed  Google Scholar 

Tibana TK, Grubert RM, Santos RFT, et al. Percutaneous nephrostomy versus antegrade double-j stent placement in the treatment of malignant obstructive uropathy: a cost-effectiveness analysis from the perspective of the brazilian public health care system. Radiol Bras. 2019;52(5):305–11. https://doi.org/10.1590/0100-3984.2018.0127.

Article  PubMed  PubMed Central  Google Scholar 

Alawneh A, Tuqan W, Innabi A, et al. Clinical factors associated with a short survival time after percutaneous nephrostomy for ureteric obstruction in cancer patients: an updated model. J Pain Symptom Manag. 2016;51(2):255–61. https://doi.org/10.1016/j.jpainsymman.2015.09.009.

Article  Google Scholar 

Chen J, Yi-cun Z, Qi-bo F, et al. Analysis of theraputic strategies of obstructive renal failure caused by advanced cervical cancer for patients failing to place the ureteral stent. J Shanghai Jiaotong Univ (Sci). 2016. https://doi.org/10.3969/j.issn.1674-8115.2015.12.032.

Article  PubMed Central  Google Scholar 

Hsu L, Li H, Pucheril D, et al. Use of percutaneous nephrostomy and ureteral stenting in management of ureteral obstruction. World J Nephrol. 2016;5(2):172. https://doi.org/10.5527/wjn.v5.i2.172.

Article  PubMed  PubMed Central  Google Scholar